T1	PROC 40 51	tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 58 76	estomatitis aftosa
#2	AnnotatorNotes T2	C0038363; Aphthous Stomatitis; Disease or Syndrome
T3	DISO 81 99	estomatitis aftosa
#3	AnnotatorNotes T3	C0038363; Aphthous Stomatitis; Disease or Syndrome
T4	DISO 142 150	lesiones
#4	AnnotatorNotes T4	C0221198; Lesion; Finding
T5	ANAT 157 169	mucosa bucal
#5	AnnotatorNotes T5	C0026639; Oral mucous membrane structure; | C1280540; Entire buccal mucosa; Tissue | C1284365; Entire oral mucous membrane; Tissue
T6	PROC 328 350	evaluar la efectividad
T7	CHEM 357 376	tintura de propóleo
T8	PROC 390 401	tratamiento
#6	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	DISO 408 426	estomatitis aftosa
#7	AnnotatorNotes T9	C0038363; Aphthous Stomatitis; Disease or Syndrome
T10	PROC 443 477	ensayo clínico fase 2 aleatorizado
#8	AnnotatorNotes T10	C0282460; Phase 2 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity
T11	CHEM 25 33	propóleo
#9	AnnotatorNotes T11	C0033488; Propolis; Biologically Active Substance; Pharmacologic Substance
T12	DISO 591 609	estomatitis aftosa
#10	AnnotatorNotes T12	C0038363; Aphthous Stomatitis; Disease or Syndrome
T13	PROC 568 587	diagnóstico clínico
#11	AnnotatorNotes T13	C0332140; Diagnosis, clinical; Diagnostic Procedure
T14	PROC 680 704	tratamiento convencional
#12	AnnotatorNotes T14	C2945704; Conventional Treatment; Therapeutic or Preventive Procedure
T15	PROC 751 763	tratamientos
#13	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	CHEM 642 650	propóleo
#14	AnnotatorNotes T16	C0033488; Propolis; Biologically Active Substance; Pharmacologic Substance
T17	PROC 1013 1024	tratamiento
#15	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	DISO 1031 1049	estomatitis aftosa
#16	AnnotatorNotes T18	C0038363; Aphthous Stomatitis; Disease or Syndrome
T19	CHEM 980 999	tintura de propóleo
T20	Dose 377 383	al 5 %
T21	LIVB 506 530	pacientes de ambos sexos
#17	AnnotatorNotes T21	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T22	Age 532 554	entre los 12 y 44 años
T23	Dose 651 657	al 5 %
T24	LIVB 663 676	grupo control
#18	AnnotatorNotes T24	C0009932; Control Groups; Group
T25	Dose 1000 1006	al 5 %
T26	LIVB 1093 1102	pacientes
#19	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	LIVB 204 213	población
#20	AnnotatorNotes T27	C1257890; Population; Population Group
T28	LIVB 615 628	grupo estudio
#21	AnnotatorNotes T28	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
R1	Used_for Arg1:T11 Arg2:T1	
R2	Location_of Arg1:T5 Arg2:T4	
R3	Location_of Arg1:T5 Arg2:T3	
R4	Experiences Arg1:T27 Arg2:T4	
R5	Experiences Arg1:T27 Arg2:T3	
R6	Has_Dose_or_Strength Arg1:T7 Arg2:T20	
R7	Used_for Arg1:T7 Arg2:T8	
R8	Has_Age Arg1:T21 Arg2:T22	
R9	Experiences Arg1:T21 Arg2:T12	
R10	Experiences Arg1:T28 Arg2:T16	
R11	Has_Dose_or_Strength Arg1:T16 Arg2:T23	
R12	Experiences Arg1:T24 Arg2:T14	
R13	Experiences Arg1:T24 Arg2:T15	
R14	Experiences Arg1:T28 Arg2:T15	
R15	Used_for Arg1:T16 Arg2:T15	
R16	Has_Dose_or_Strength Arg1:T19 Arg2:T25	
R17	Used_for Arg1:T19 Arg2:T17	
T29	Observation 1126 1160	mejoramiento de la calidad de vida
#22	AnnotatorNotes T29	C2015892; outcomes general quality of life improved; Finding
R18	Experiences Arg1:T26 Arg2:T29	
T30	Observation 1072 1085;1103 1120	incorporación a sus actividades
T31	Quantifier_or_Qualifier 1065 1071	rápida
#23	AnnotatorNotes T31	C0456962; Rapid; Qualitative Concept
R20	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T31	
T32	CONC 1145 1160	calidad de vida
#24	AnnotatorNotes T32	C0034380; Quality of life; Idea or Concept
#25	AnnotatorNotes T6	C1707887; Efficacy Study; Research Activity
A1	Experiencer T26 Patient
A2	Experiencer T24 Patient
A3	Experiencer T28 Patient
A4	Experiencer T27 Patient
A5	Experiencer T21 Patient
